This translational study identified that the detection of PIK3CA mutations in three hotspots and combining tumor and circulating DNA assessment using robust ddPCR was predictive of a reduction in both progression-free and overall survival in a clinically important sub-group of cervical adenocarcinoma. The gene discussed is PIK3CA; the disease is neoplasm.